Global Chemiluminescence Analyzer (CLA) Market 2017-2021

  • ID: 4307401
  • Report
  • Region: Global
  • 76 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Biokit
  • bioMérieux SA
  • DiaSorin
  • F. Hoffmann-La Roche
  • MORE
About Chemiluminescence Analyzer (CLA)

A chemiluminescence analyzer can be defined as a device that detects radiation or light produced in a chemical reaction when a chemical entity returns from an electronic excited state to its stable form. This excitation is achieved through oxidation or chemical catalysis. In vitro diagnostic (IVD) devices are medical devices that are used to perform tests on samples such as blood or urine to diagnose medical conditions and prevent chronic diseases.

The analysts forecast the global chemiluminescence analyzer market to grow at a CAGR of 6.41% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global chemiluminescence analyzer market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of CLAs to the various end-users.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Chemiluminescence Analyzer Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Beckman Coulter
- bioMérieux SA
- F. Hoffmann-La Roche
- Siemens Healthineers

Other prominent vendors
- Biokit
- DiaSorin
- Ortho Clinical Diagnostics

Market drivers
- Predictive and preventive medicine for early diagnosis and treatment
- For a full, detailed list, view the full report

Market challenges
- Lack of accessibility and affordability of diagnostic tests in developing countries
- For a full, detailed list, view the full report

Market trends
- Adoption of standardization and automation across the in vitro diagnostics industry
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key Market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are theKey vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Biokit
  • bioMérieux SA
  • DiaSorin
  • F. Hoffmann-La Roche
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Five forces analysis
PART 06: Market segmentation by product type
  • Market overview
PART 07: Market segmentation by end-user
  • Market overview
PART 08: Geographical segmentation
  • Market Overview
  • CLA market in EMEA
  • CLA market in Americas
  • CLA market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends

PART 12: Vendor landscape
  • Competitive scenario
PART 13: Key vendor analysis
  • Abbott Laboratories
  • Beckman Coulter
  • bioMérieux SA
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Applications of IVDs
Exhibit 02: Global CLA market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global CLA market by product type 2016 and 2021
Exhibit 05: Global benchtop CLA market 2016-2021 ($ millions)
Exhibit 06: Global floor-standing CLA market 2016-2021 ($ millions)
Exhibit 07: Global CLA market by end-users 2016 and 2021
Exhibit 08: Global CLA market by hospitals and diagnostic centers 2016-2021 ($ millions)
Exhibit 09: Advantages of CLAs for hospitals and diagnostic centers
Exhibit 10: Global CLA market by research laboratories 2016-2021 ($ millions)
Exhibit 11: Global CLA market by pharma and biotech companies 2016-2021 ($ millions)
Exhibit 12: Global CLA market by academic research centers 2016-2021 ($ millions)
Exhibit 13: Global CLA market by geography 2016 and 2021
Exhibit 14: CLA market in EMEA 2016-2021 ($ millions)
Exhibit 15: CLA market in Americas 2016-2021 ($ millions)
Exhibit 16: Market facts highlighting the increase in personalized medicine
Exhibit 17: Share of personalized medicines across different disease areas
Exhibit 18: CLA market in APAC 2016-2021 ($ millions)
Exhibit 19: Advantages of disease diagnosis
Exhibit 20: Advantages of predictive and preventive medicine
Exhibit 21: Importance of diagnostics in identifying correct respondents for correct therapy
Exhibit 22: Advantages of CLIA over ELISA
Exhibit 23: Barriers for diagnostics market in developing countries
Exhibit 24: Strategic success factors for companies
Exhibit 25: Abbott Laboratories: Profile
Exhibit 26: Abbott Laboratories: Strength analysis
Exhibit 27: Abbott Laboratories: Strategy assessment
Exhibit 28: Abbott Laboratories: Opportunity assessment
Exhibit 29: Beckman Coulter: Profile
Exhibit 30: Beckman Coulter: Strength analysis
Exhibit 31: Beckman Coulter: Strategy assessment
Exhibit 32: Beckman Coulter: Opportunity assessment
Exhibit 33: bioMérieux: Profile
Exhibit 34: bioMérieux: Strength analysis
Exhibit 35: bioMérieux: Strategy assessment
Exhibit 36: bioMérieux: Opportunity assessment
Exhibit 37: F. Hoffmann-La Roche: Profile
Exhibit 38: F. Hoffmann-La Roche: Strength analysis
Exhibit 39: F. Hoffmann-La Roche: Strategy assessment
Exhibit 40: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 41: Siemens Healthineers: Profile
Exhibit 42: Siemens Healthineers: Strength analysis
Exhibit 43: Siemens Healthineers: Strategy assessment
Exhibit 44: Siemens Healthineers: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter
  • Biokit
  • bioMérieux SA
  • DiaSorin
  • F. Hoffmann-La Roche
  • MORE
New Report Released: – Global Chemiluminescence Analyzer (CLA) Market 2017-2021

The author of the report recognizes the following companies as the key players in the global chemiluminescence analyzer market: Abbott Laboratories, Beckman Coulter, bioMérieux SA, F. Hoffmann-La Roche, and Siemens Healthineers.

Other Prominent Vendors in the market are: Biokit, DiaSorin, and Ortho Clinical Diagnostics.

Commenting on the report, an analyst from the research team said: “One trend in the market is adoption of standardization and automation across the in vitro diagnostics industry. Due to the cost cutting in clinical lab fees, profitability, per test, is decreasing, which makes it necessary for the laboratories to focus on volume rather than value. There is also heavy pressure for quality, error-free results.”

According to the report, one driver in the market is predictive and preventive medicine for early diagnosis and treatment. Globally, there is a trend in the world of medicine to transform from reactive healthcare to preventive healthcare. The changes as part of this trend will be propelled by new approaches to disease that will trigger the emergence of predictive and preventive medicine ultimately leading to personalized medicinal procedures.

Further, the report states that one challenge in the market is lack of accessibility and affordability of diagnostic tests in developing countries. High-quality diagnostic tests are easily available for various diseases in the majority of the developed countries however, they are neither affordable nor accessible in developing countries, where disease burden is high. Management of disease by addressing symptoms is ineffective and increases the risk of antibiotic resistance.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • Beckman Coulter
  • bioMérieux SA
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Biokit
  • DiaSorin
  • Ortho Clinical Diagnostics.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll